0% found this document useful (0 votes)
69 views5 pages

Title 1 Key Words 2 3a: SCARE 2018 Checklist Topic Item Checklist Item Description Number

Download as pdf or txt
Download as pdf or txt
Download as pdf or txt
You are on page 1/ 5

SCARE 2018 Checklist

Page
Topic Item Checklist item description
Number

Title The words “case report” should appear in the title. The title
1
should also describe the area of focus (e.g. presentation,
Key diagnosis,
3 to 6 keysurgical
words technique or device
that identify areas or outcome).
covered in this case
2
Words report (include "case report" as one of the keywords).
Abstract Introduction — Describe what is unique or educational about
3a the case (i.e. what does this work add to the surgical literature,
and why is this important?).

Presenting complaint and investigations – describe the


3b
patient's main concerns and important clinical findings.

The main diagnoses, therapeutics interventions, and


3c
outcomes.

Conclusion — Describe the main lessons to “take-away” from


3d
this case study

Introducti Background – summarise what is unique or educational


on about the case. Give reference to the relevant surgical
4
literature and current standard of care. The background
should be referenced, and 1-2 paragraphs in length.

Patient Demographic details – include de-identified demographic


Informatio details on patient age, sex, ethnicity, occupation. Where
5a
n possible, include other useful pertinent information e.g.
body mass index and hand dominance.

Presentation - describe the patient’s presenting


complaint (symptoms). Describe the patient’s mode of
5b
presentation (brought in by ambulance or walked into
Emergency room or referred by family physician).

Past medical and surgical history, and relevant outcomes


5c
from interventions
Other histories – Describe the patient’s pharmacological
history including allergies, psychosocial history (Drug,
5d
smoking, and if relevant, accommodation, walking aids),
family history including relevant genetic information.

Clinical Describe the relevant physical examination and other


Findings 6 significant clinical findings. Include clinical photographs
where relevant and where consent has been given.

Timeline Inclusion of data which allows readers to establish the


sequence and order of events in the patient's history and
7
presentation (using a table or figure if this helps). Delay
from presentation to intervention should be reported.

Diagnosti Diagnostic methods – describe all investigations taken to


c 8a arrive at methods: physical exam, laboratory testing,
Assessme radiological imaging, histopathology.
nt Diagnostic challenges – describe what was challenging
8b about the diagnoses, where applicable, for example
access, financial, cultural.

Diagnostic reasoning – Describe the differential


8c
diagnoses and why they were considered.

Prognostic characteristics when applicable (e.g. tumour


8d staging or for certain genetic conditions). Include relevant
radiological or histopathological images in this section.

Therapeut Pre-intervention considerations – if there were patient-specific


ic optimisation measures taken prior to surgery or other
Interventi intervention these should be included e.g. treating
9a
on hypothermia/hypovolaemia/hypotension in a burns patient,
Intensive care unit treatment for sepsis, dealing with
anticoagulation/other medications, etc.

Interventions – describe the type(s) of intervention(s) deployed


9b (pharmacologic, surgical, physiotherapy, psychological,
preventive). Describe the reasoning behind this treatment
offered. Describe any concurrent treatments (antibiotics,
analgesia, anti-emetics, nil by mouth, Venous thrombo-
embolism prophylaxis, etc). Medical devices should have
manufacturer and model specifically mentioned.

Intervention details – describe what was done and how. For


surgery include details on; anaesthesia, patient position, use of
tourniquet and other relevant equipment, prep used, sutures,
devices, surgical stage (1 or 2 stage, etc). For pharmacological
9c therapies include information on the formulation, dosage,
strength, route, duration, etc. Include intra-operative
photographs and/or video or relevant histopathology in this
section. Degree of novelty for a surgical technique/device
should be mentioned e.g. "first in human".

Who performed the procedure - operator experience (position


on the learning curve for the technique if established,
9d
specialisation and prior relevant training). For example, “junior
resident with 3 years of specialised training”

Changes – if there were any changes in the interventions,


9e
describe these details with the rationale.

Follow-up Follow-up – describe 1) When the patients was followed up. 2)


and Where. 3) How (imaging, tests, scans, clinical examination,
Outcomes phone call), and 4) whether there were any specific post-
10a operative instructions. Future surveillance requirements - e.g.
imaging surveillance of endovascular aneurysm repair or
clinical exam/ultrasound of regional lymph nodes for skin
cancer.

Outcomes - Clinician assessed and (when appropriate) patient-


reported outcomes (e.g. questionnaire details). Relevant
10b
photographs/radiological images should be provided e.g. 12
month follow-up.

Intervention adherence/compliance - where relevant how well


10c
patient adhered to and tolerated their treatment. For example,
post-operative advice (heavy lifting for abdominal surgery) or
tolerance of chemotherapy and pharmacological agents

Complications and adverse events – all complications and


adverse or unanticipated events should be described in detail
and ideally categorised in accordance with the Clavien-Dindo
Classification. How they were prevented, diagnosed and
10d managed. Blood loss, operative time, wound complications, re-
exploration/revision surgery, 30-day post-op and long-term
morbidity/mortality may need to be specified. If there were no
complications or adverse outcomes this should also be
included.

Discussio 11a Strengths – describes the strengths of this case


n Weaknesses and limitations in your approach to this case. For
new techniques or implants - contraindications and
alternatives, potential risks and possible complications if
11b
applied to a larger population. If relevant, has the case been
reported to the relevant national agency or pharmaceutical
company (e.g. an adverse reaction to a device)

Discussion of the relevant literature, implications for clinical


11c
practice guidelines and any relevant hypothesis generation.

11d The rationale for your conclusions.

11e The primary “take-away” lessons from this case report.

Patient
Perspectiv 12 When appropriate the patient should share their perspective on
e the treatments they received.

Informed Did the patient give informed consent for publication? Please
Consent provide if requested by the journal/editor. If not given by the
patient, explain why e.g. death of patient and consent provided
13
by next of kin or if patient/family untraceable then document
efforts to trace them and who within the hospital is acting as a
guarantor of the case report.
Additional
Informatio 14 Conflicts of Interest, sources of funding, institutional review
n board or ethical committee approval where required.

You might also like